A. Thyss

发表

Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies.

E. Goillot, G. Delsol, V. Combaret, 1991, British Journal of Cancer.

Dual-point FDG-PET/CT for treatment response assessment in Hodgkin lymphoma, when an FDG-avid lesion persists after treatment.

J. Darcourt, J. Zaucha, S. Morbelli, 2019, American journal of nuclear medicine and molecular imaging.

Thermo-ablation par ultrasons focalisés de haute intensité guidés par l’IRM, un traitement local prometteur en oncologie

A. Iannessi, A. Thyss, A. Leysalle, 2014 .

Magnetic resonance guided focalised ultrasound thermo-ablation: a promising oncologic local therapy.

A. Iannessi, A. Thyss, A. Leysalle, 2014, Diagnostic and interventional imaging.

Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.

G. Poissonnet, P. Marcy, O. Dassonville, 1998, International journal of radiation oncology, biology, physics.

Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group

F. Baron, H. Zwierzina, K. Indrák, 2012, Haematologica.

Irradiation des sarcomes cardiaques de l’adulte

N. Isambert, V. Beckendorf, J. Thariat, 2014 .

Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.

F. Bertucci, S. Salas, A. Italiano, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[Population study of dihydropyrimidine dehydrogenase in cancer patients].

O. Dassonville, F. Demard, G. Milano, 1994, Bulletin du cancer.

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

O. Dassonville, F. Demard, G. Milano, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

One-bloc percutaneous large biopsy of soft-tissue tumours: feasibility study and possible indications.

M. Liberatore, A. Iannessi, A. Thyss, 2019, Clinical radiology.

Childhood cancer incidence in the south-east of France. A report of the Provence-Alpes-Côte d'Azur and Corsica Regions Pediatric Cancer Registry, 1984-1991.

J. Bernard, G. Michel, J. Gentet, 1993, European journal of cancer.

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

X. Pivot, P. Guerrier, D. Cupissol, 2000, Oncology.

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

J. Blay, B. Bui, A. Cesne, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

P. Biron, P. Viens, C. Fuhrmann, 1998, The Journal of antimicrobial chemotherapy.

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.

Y. Bertrand, F. Méchinaud, S. Suciu, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.

J. Blay, J. Coindre, S. Mathoulin-Pélissier, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.

J. Thariat, L. Juillard, G. Deray, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymphomatous superficial lymph nodes: US detection.

C. Balu-Maestro, A. Thyss, J. Bruneton, 1987, Radiology.

Cerebellar relapse of Hodgkin lymphoma

J. Thariat, F. Vandenbos, A. Thyss, 2009, Leukemia & lymphoma.

Hodgkin’s Lymphoma in Older Patients: an Orphan Disease?

F. Peyrade, A. Thyss, E. Saâda, 2014, Mediterranean journal of hematology and infectious diseases.

A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma

Scott E. Smith, K. Papadopoulos, A. Thyss, 2016, Leukemia & lymphoma.

Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review

J. Darcourt, P. Bondiau, R. Gressin, 2008, Leukemia & lymphoma.

Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?

G. Poissonnet, P. Marcy, O. Dassonville, 2004, Cancer.

Meningeal SMARCB 1-deficient tumors : an emerging group of meningeal tumors

P. Varlet, A. Jouvet, J. Coindre, 2016 .

High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: A preventive mechanism of malignant tumor cells against complement attack?

P. Hofman, B. Rossi, P. Fénichel, 2004, Breast Cancer Research and Treatment.

Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy

A. Naghavi, J. Lacour, A. Thyss, 2017, JAMA dermatology.

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

B. Coiffier, É. Oksenhendler, C. Gisselbrecht, 1993 .

Brain metastases of lung cancer: excessive toxicity of high dose VP 16 213.

J. Lagrange, A. Thyss, M. Frénay, 1988, European journal of cancer & clinical oncology.

Renal tolerance of cisplatin in patients more than 80 years old.

O. Dassonville, M. Gaspard, A. Thyss, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mucosal Kaposi sarcoma, a Rare Cancer Network study

T. Sio, J. Thariat, G. Poissonnet, 2012, Rare tumors.

Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation.

Marc C. Jacob, J. Rossi, R. Gressin, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumour response to paclitaxel in an adult with relapsed nephroblastoma.

A. Italiano, F. Peyrade, J. Michiels, 2005, The Lancet. Oncology.

Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.

C. Mottolese, J. Stéphan, J. Zucker, 1995, Journal of neurosurgery.

Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy

J. Thariat, O. Dassonville, F. Peyrade, 2008, Sarcoma.

Non-seminomatous ovarian germ cell tumours in children.

C. Patte, E. Bouffet, A. Thyss, 2000, European journal of cancer.

Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report

A. Gallamini, F. Peyrade, A. Thyss, 2017, Hematological oncology.

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

F. Peyrade, S. Caruso, A. Thyss, 2015, Experimental Hematology & Oncology.

Are nilotinib‐associated vascular adverse events an under‐estimated problem?

M. Drici, A. Thyss, F. Rocher, 2015, Fundamental & clinical pharmacology.

Very high endothelin plasma levels in patients with 5-FU cardiotoxicity.

G. Milano, R. Marsault, C. Frelin, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Dihydropyrimidine dehydrogenase activity in cancer patients.

F. Demard, G. Milano, R. Fleming, 1993, European journal of cancer.

Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.

F. Demard, G. Milano, R. Fleming, 1992, Cancer research.

Composite carcinoma of the lung simulating small-cell carcinoma in a child.

J. Valla, N. Sirvent, A. Thyss, 1999, Medical and pediatric oncology.

Expression of integrin receptors on 45 clinical neuroblastoma specimens

D. Frappaz, E. Goillot, V. Combaret, 1991, International journal of cancer.

Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit.

G. Milano, P. Cambon, A. Thyss, 1990, British Journal of Cancer.

Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.

M. Namer, G. Milano, A. Thyss, 1985, British Journal of Cancer.

Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas

F. Demard, J. Santini, J. Vallicioni, 1990, Head & neck.

Home Infusions of Biphosphonate in Cancer Patients: A Prospective Study

P. Marcy, R. Largillier, J. Ferrero, 2006 .

Home infusions of biphosphonate in cancer patients: a prospective study.

A. Italiano, P. Marcy, R. Largillier, 2006, Journal of chemotherapy.

GOELAMS with final results after a median follow-up of 9 years advanced follicular lymphoma: a randomized multicenter study by the transplantation and doxorubicin-based chemotherapy in patients with High-dose therapy followed by autologous purged stem cell

E. Deconinck, P. Colombat, N. Milpied, 2013 .

[Six cases of pulmonary MALT lymphoma: a heterogeneous therapeutic management].

C. Marquette, J. Thariat, J. Mouroux, 2011, Revue de pneumologie clinique.

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.

E. Deconinck, P. Colombat, N. Milpied, 2009, Blood.

Cisplatin Nephrotoxicity: A Multivariate Analysis of Potential Predisposing Factors

X. Pivot, G. Milano, J. Ferrero, 1997, Pharmacotherapy.

[Combination transurethral resection and systematic chemotherapy as primary treatment of infiltrating bladder tumors (pT2-pT4 NxM0)].

H. Quintens, A. Thyss, C. Caldani, 1988, Journal d'urologie.

Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer

F. Demard, G. Milano, J. Vallicioni, 2004, Cancer Chemotherapy and Pharmacology.

Circulating drug levels in patients presenting cardiotoxicity to 5-FU.

F. Demard, G. Milano, A. Thyss, 1988, European journal of cancer & clinical oncology.

[Radiation therapy of cardiac sarcomas].

J. Thariat, N. Isambert, V. Beckendorf, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Inhibition of dihydropyrimidine dehydrogenase by α-interferon: experimental data on human tumor cell lines

L. Thill, G. Milano, J. Fischel, 2004, Cancer Chemotherapy and Pharmacology.

The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions.

J. Thariat, R. Bensadoun, Y. Rostom, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab

R. Schiappa, F. Peyrade, E. Chamorey, 2018, Hematological oncology.

BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST‐LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL)

R. Schiappa, A. Gallamini, E. Chamorey, 2017, Hematological Oncology.

Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia

A. Italiano, F. Peyrade, A. Thyss, 2008, British journal of haematology.

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.

K. Hoang-Xuan, O. Chinot, N. Martin-Duverneuil, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS)

K. Hoang-Xuan, O. Chinot, P. Morel, 2016 .

A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998, Cancer.

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

H. Cavé, Y. Bertrand, M. Fournier, 2000, Leukemia.

New sequential treatment with chemotherapy and reduced‐intensity conditioning for allogeneic stem‐cell transplantation in very high‐risk acute myeloid leukemia

N. Mounier, L. Mannone, T. Cluzeau, 2011, American journal of hematology.

Pharmacokinetics of weekly low dose doxorubicin.

M. Namer, G. Milano, A. Thyss, 1989, European journal of cancer & clinical oncology.

Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profile.

M. Namer, G. Milano, J. Fischel, 1992, European journal of cancer.

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.

B. Bui, P. Fargeot, D. Cupissol, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.

F. Demard, J. Santini, J. Vallicioni, 1986, British Journal of Cancer.

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

N. Magné, X. Pivot, G. Milano, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Salivary passage of 5-fluorouracil during continuous infusion

F. Demard, J. Santini, G. Milano, 2004, Cancer Chemotherapy and Pharmacology.

Combination of Cisplatin‐Doxorubicin‐Cyclophosphamide in Adenocarcinoma of Unknown Primary Site: A Phase II Trial

N. Magné, X. Pivot, A. Thyss, 2001, American journal of clinical oncology.

Reevaluation of alkaline phosphatase measurement during Hodgkin's disease by electrophoretic isoenzyme separation.

A. Thyss, C. Caldani, M. Schneider, 1985, British Journal of Cancer.

Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapy

M. Namer, G. Milano, A. Thyss, 2004, Cancer Chemotherapy and Pharmacology.

Aromatase inhibition in male breast cancer patients: biological and clinical implications.

A. Italiano, R. Largillier, J. Ferrero, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Aromatase inhibition in male breast cancer patients: Biological and clinical implications.

R. Largillier, J. Ferrero, A. Thyss, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome.

M. Drici, A. Thyss, P. Gibelin, 1993, British heart journal.

Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.

O. Dassonville, F. Demard, G. Milano, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].

F. Demard, L. Leborgne, A. Thyss, 1987, Bulletin du cancer.

Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies.

G. Milano, A. Thyss, A. Deville, 1987, European journal of cancer & clinical oncology.

Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer.

M. Namer, J. Ferrero, J. Lagrange, 1997, Journal of clinical pathology.

Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusion.

G. Milano, J. Lagrange, A. Thyss, 1993, Journal of the National Cancer Institute.

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.

F. Demard, G. Milano, R. Fleming, 1992, British Journal of Cancer.

Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancers

O. Dassonville, F. Demard, J. Santini, 1994 .

Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib

N. Magné, F. Demard, X. Pivot, 2003 .

Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment.

A. Italiano, F. Peyrade, A. Thyss, 2007, The Lancet. Oncology.

Fluorouracil in Cancer Patients in Peripheral Mononuclear Cells and Systemic Clearance of Correlation between Dihydropyrimidine Dehydrogenase Activity

G. Milano, Étienne, Maurice Schneider, 2006 .

Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.

K. Bénézery, F. Peyrade, B. Guillot, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF)

H. Gerhartz, P. Sonneveld, R. Marcus, 1992, Infection.

Clinical pharmacokinetics of Pure 1 Folinic Acid and Fluorouracil during a phase I–II trial of Fluorouracil biomodulation in head and neck cancer patients. Preliminary data

O. Dassonville, F. Demard, G. Milano, 1994 .

Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.

F. Millot, H. Rubié, A. Thyss, 1994, Leukemia & lymphoma.

CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group.

D. Frappaz, G. Milano, G. Laureys, 1990, European journal of cancer.

Comparison of natural killer activity during the first and second halves of the menstrual cycle in women.

A. Thyss, C. Caldani, M. Schneider, 1984, British Journal of Cancer.

Conservative Multimodal Management of a Primitive Neuroectodermal Tumor of the Thyroid

J. Thariat, P. Marcy, A. Bozec, 2013, Rare tumors.

Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.

M. Héry, J. Lagrange, A. Thyss, 1988, Bulletin du cancer.

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.

S. Salas, A. Italiano, J. Thariat, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

P. Maes, Y. Bertrand, J. van der Werff Ten Bosch, 2005, Leukemia.

[Management of targeted therapies in hemodialysis patients].

J. Thariat, G. Deray, V. Launay-Vacher, 2012, Bulletin du Cancer.

[Management of chemotherapy in hemodialysis patients].

J. Thariat, G. Deray, V. Launay-Vacher, 2012, Bulletin du cancer.

CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN

M. Namer, G. Milano, A. Thyss, 1986, The Lancet.

Dermatomyositis-like syndrome in X-linked hypogammaglobulinemia. Case-report and review of the literature.

J. Ortonne, A. Thyss, P. el Baze, 1990, Acta dermato-venereologica.

Pseudomonas aeruginosa O-11 folliculitis. Development into ecthyma gangrenosum in immunosuppressed patients.

J. Ortonne, A. Thyss, P. el Baze, 1985, Archives of dermatology.

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2005, Leukemia.

Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.

M. Gari-Toussaint, A. Thyss, C. Roux, 2013, Journal de mycologie medicale.

[Kaposi sarcoma of the lungs in patients with acquired immunodeficiency syndrome (AIDS). Thoracic radiography and scanning].

J. Sedat, S. Chanalet, J. Mouroux, 1993, Journal de radiologie.

[Role of radiotherapy in the management of non-Hodgkin lymphomas].

J. Thariat, F. Peyrade, B. Rossignol, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

J. Blay, M. van Glabbeke, J. Verweij, 2008, European journal of cancer.

Paclitaxel in patients (pts) with advanced angiosarcomas

J. Blay, J. Verweij, M. Schlemmer, 2007 .

Not all sarcomas developed in irradiated tissue are necessarily radiation-induced--spectrum of disease and treatment characteristics.

A. Italiano, J. Thariat, P. Marcy, 2012, Critical reviews in oncology/hematology.

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

J. Rossi, R. Gressin, E. Deconinck, 2010, British journal of haematology.

A multivariate analysis of the survival of patients with aggressive lymphoma

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998 .

Vitiligo-like depigmentation and morpheas after specific intralymphatic immunotherapy for malignant melanoma.

J. Ortonne, J. Lacour, A. Thyss, 1992, Dermatology.

Methylated catecholamine metabolites for diagnosis of neuroblastoma.

M. Candito, A. Thyss, A. Deville, 1992, Medical and pediatric oncology.

Orosomucoid:prealbumin ratio--a marker of the host-tumor relationship in head and neck cancer.

F. Demard, G. Milano, A. Thyss, 1988, European journal of cancer & clinical oncology.

Isolated bilateral adrenal choriocarcinoma.

A. Bongain, J. Bernard, C. Trastour, 2005, The Lancet. Oncology.

Comparative study of gamma glutamyl transferase, alkaline phosphatase and its alpha 1 isoenzyme as biological indicators of liver metastases.

A. Ramaioli, P. Cambon, G. Viot, 1981, Clinica chimica acta; international journal of clinical chemistry.

Extragestational βHCG secretion due to an isolated lung epithelioid trophoblastic tumor: microsatellite genotyping of tumoral cells confirmed their placental origin and oriented specific chemotherapy.

P. Chevallier, J. Mouroux, P. Fénichel, 2014, The Journal of clinical endocrinology and metabolism.

[Subcutaneous sacrococcygeal ependymoma].

A. Thyss, G. Rostain, J. Michiels, 1987, Pediatrie.

Thyroid spindle epithelial tumor with thymus-like differentiation (the “settle” tumor)

C. Mainguené, A. Thyss, A. Pagès, 1995, European Archives of Oto-Rhino-Laryngology.

Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients.

F. Lévi, G. Milano, A. Thyss, 1988, Cancer research.

Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.

P. Terrier, F. Oberling, O. Feugeas, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease

J. Thariat, P. Marcy, G. Milano, 2011, Cancer Chemotherapy and Pharmacology.

Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

E. Clappier, H. Cavé, P. Rohrlich, 2015, Annals of Hematology.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.

N. Dastugue, A. Uyttebroeck, S. Suciu, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

H. Cavé, Y. Bertrand, M. Fournier, 2000, Leukemia.

Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.

A. Thyss, P. Freychet, J. Sadoul, 1992, Acta endocrinologica.

An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia.

N. Magné, X. Pivot, G. Milano, 2000, European journal of cancer.

Improved survival using specialized multidisciplinary board in sarcoma patients.

J. Blay, F. Bertucci, S. Bonvalot, 2017 .

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

Y. Bertrand, S. Suciu, Y. Benoît, 1994, British journal of haematology.

Treatment decisions for elderly patients with haematological malignancies: a dilemma.

F. Peyrade, A. Thyss, D. Ré, 2012, The Lancet. Oncology.

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

F. Jardin, P. Gaulard, B. Coiffier, 2011, The Lancet. Oncology.

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

J. Blay, B. Coiffier, R. Bouabdallah, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

R. Gressin, E. Deconinck, P. Cornillet‐Lefèbvre, 2005, Blood.

Thrombocytopenia, the acquired immunodeficiency syndrome (AIDS), and zidovudine.

A. Thyss, G. Garnier, P. Viens, 1988, Annals of internal medicine.

Meningeal SWI/SNF related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily B member 1 (SMARCB1)‐deficient tumours: an emerging group of meningeal tumours

P. Varlet, A. Jouvet, J. Coindre, 2017, Neuropathology and applied neurobiology.

The Children Leukemia Group: 30 years of research and achievements.

S. Suciu, A. Ferster, A. Babin-Boilletot, 2002, European journal of cancer.

Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients.

M. Namer, G. Milano, A. Thyss, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-energy He/Ne laser in the prevention of radiation-induced mucositis

V. Darcourt, G. Poissonnet, O. Dassonville, 1999, Supportive Care in Cancer.

Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?

P. Bahadoran, J. Ortonne, C. Bertolotto, 2011, Experimental dermatology.

High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.

D. Frappaz, J. Stéphan, J. Zucker, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The off-label use of targeted therapies in sarcomas: the OUTC’S program

J. Blay, F. Bertucci, A. Le Cesne, 2014, BMC Cancer.

Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.

J. Thariat, J. Salleron, P. Chevallier, 2020, Bulletin du cancer.

Efficacy of lenograstim on hematological tolerance to maid chemotherapy in sarcoma patients and impact on dose intensity

P. Fargeot, D. Cupissol, F. Bonichon, 1993 .

Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.

C. Patte, E. Benhamou, O. Hartmann, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

J. Stéphan, E. Sariban, E. Bouffet, 1998, British Journal of Cancer.

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.

O. Delattre, D. Frappaz, H. Avet-Loiseau, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

G. Leverger, J. Stéphan, C. Bergeron, 2000, British Journal of Cancer.

The acquired immunodeficiency syndrome-related complex (ARC) in a child of drug-addicted parents.

A. Thyss, A. Deville, D. Dupont, 1987, Annals of internal medicine.

Improved survival using specialized multidisciplinary board in sarcoma patients

F. Bertucci, S. Bonvalot, A. Cesne, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

J. Blay, S. Salas, B. Bui, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.

F. Bertucci, M. Toulmonde, A. Le Cesne, 2015, The Lancet. Oncology.

Altered pharmacokinetics and clinical consequences of low dose methotrexate plus cisplatin in the treatment of advanced head and neck cancer.

F. Demard, J. Santini, G. Milano, 1986, European journal of cancer & clinical oncology.

Treating metastatic sarcomas locally: a paradoxe, a rationale, an evidence?

J. Blay, J. Thariat, D. Cupissol, 2015, Critical reviews in oncology/hematology.

Results of randomized, placebo (PL)-controlled phase II study evaluating efficacy and safety of regorafenib (REG) in patients (pts) with metastatic osteosarcoma (metOS), on behalf of the French Sarcoma Group (FSG) and Unicancer.

J. Blay, O. Mir, A. Italiano, 2018 .

elderly multiple myeloma patients ineligible for high-dose therapy Dexamethasone-based regimens versus melphalan-prednisone for

J. Rossi, R. Bataille, I. Yakoub-Agha, 2011 .

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Augustin Ferrant, Chantal Doyen, J. Rossi, 2006 .

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

Catherine Thieblemont, Nicolas Mounier, Richard Delarue, 2013, The Lancet. Oncology.

Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.

P. Paquis, G. Milano, J. L. Roche, 1989, British Journal of Cancer.

Improved sarcoma management in a national network of reference centers: Analysis of the NetSarc network on 13,454 patients treated between 2010 and 2014.

J. Blay, F. Bertucci, A. Cesne, 2016 .

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years

J. Blay, F. Bertucci, O. Mir, 2019, International journal of cancer.

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

V. Servois, S. Piperno-Neumann, F. Mouriaux, 2016, British Journal of Cancer.

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.

J. Radford, L. Trümper, L. Arcaini, 2016, The Lancet. Oncology.

DESMOPAZ pazopanib (PZ) versus IV methotrexate/vinblastine (MV) in adult patients with progressive desmoid tumors (DT) a randomized phase II study from the French Sarcoma Group.

J. Blay, F. Bertucci, F. Petitprez, 2018 .

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

J. Blay, S. Salas, B. Bui, 2012 .

Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol

T. Molina, B. Coiffier, H. Tilly, 2010, Leukemia & lymphoma.

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and

P. Sonneveld, A. Hagemeijer, Z. Berneman, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Prognostic Factors for Patients with Recurrent Head and Neck Cancer: Implications for Randomized Trials

G. Poissonnet, O. Dassonville, F. Demard, 2001, Oncology.

Primary Embryonal Rhabdomyosarcoma of the Breast in an Adult Female

A. Italiano, R. Largillier, A. Thyss, 2005, The Breast Journal.

[Follicular dendritic cell sarcoma in head and neck region].

J. Thariat, X. Sun, J. Haudebourg, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Primary lymphosarcoma of the breast. 4 cases].

M. Héry, M. Namer, A. Thyss, 1982, La Nouvelle presse medicale.

[Primary lymphoma of the cranial vault. Apropos of a case].

P. Paquis, J. L. Roche, M. Lonjon, 1993, Neuro-Chirurgie.

Osteosarcomas of the mandible: are they different from other tumor sites?

A. Italiano, J. Thariat, G. Odin, 2012, Critical reviews in oncology/hematology.

Ovarian metastasis from choroidal melanoma.

P. Chevallier, D. Ambrosetti, A. Thyss, 2008, Clinical imaging.

Induction chemotherapy with Cisplatin and 5-FU for squamous cell carcinoma of the head and neck. Six years experience at the Nice Cancer Center

O. Dassonville, F. Demard, J. Santini, 1991 .

Neo-Adjuvant intra-arterial chemotherapy by Cisplatin and 5-FU for squamous cell carcinoma of the oral cavity

O. Dassonville, F. Demard, J. Santini, 1991 .

Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.

A. Italiano, P. Marcy, D. Fontaine, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationship between fluorouracil systemic exposure and tumor response and patient survival.

A. Ramaioli, F. Demard, G. Milano, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic medulloblastoma: the experience of the French Cooperative M7 Group.

E. Bouffet, C. Lasset, F. Doz, 1994, European journal of cancer.

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

F. Demard, J. Santini, G. Milano, 1989, British Journal of Cancer.

Primary lung sarcomas: long survivors obtained with iterative complete surgery.

N. Magné, P. Marcy, X. Pivot, 2001, Lung cancer.

Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.

G. Levitt, G. Margueritte, M. Tournade, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.

A. Italiano, S. Piperno-Neumann, N. Penel, 2015, European journal of cancer.

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

J. Blay, S. Leprêtre, H. Tilly, 2011, Hematological oncology.

High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma

N. Magné, P. Bondiau, A. Thyss, 2000, Bone Marrow Transplantation.

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs

O. Decaux, A. Lamblin, P. Moreau, 2013, Thrombosis and Haemostasis.

Classification of Malignant Lymphomas

A. Thyss, M. Schneider, 1986 .

Severe interaction between methotrexate and a macrolide-like antibiotic.

G. Milano, P. Jambou, E. Cassuto‐Viguier, 1993, Journal of the National Cancer Institute.

Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.

X. Pivot, A. Thyss, M. Schneider, 1999, Hematology and Cell Therapy.

α-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia

F. Guilhot, P. Brice, F. Millot, 2002 .

Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia.

F. Guilhot, P. Brice, F. Millot, 2002, Journal of pediatric hematology/oncology.

Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation

R. Ballotti, T. Zenz, G. Robert, 2013, Haematologica.

High‐dose therapy in multiple myeloma: A prospective randomized study of the “intergroupe français du myelome”

N. Ifrah, J. Harousseau, M. Attal, 1995 .

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

J. Blay, J. Coindre, S. Mathoulin-Pélissier, 2009, Investigational New Drugs.

High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma

D. Coso, H. Naman, F. Peyrade, 2015, Leukemia & lymphoma.

Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma

F. Peyrade, E. Chamorey, C. Foussard, 2005, Oncology.

Results of a Phase II Trial Testing Interferon Alpha 2b and Cytarabine in Children with Chronic Myelogenous Leukemia.

G. Leverger, T. Leblanc, F. Guilhot, 2004 .

[Renal involvement in cancer and renal paraneoplastic syndromes].

A. Ravaud, J. Thariat, P. Marcy, 2012, Bulletin du cancer.

Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.

F. Jardin, H. Tilly, A. Italiano, 2005, Haematologica.

Phase II Trial of Paclitaxel–Epirubicin in Patients With Recurrent Soft-Tissue Sarcoma

X. Pivot, J. Bay, M. Mita, 2002, American journal of clinical oncology.

BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST‐LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL).

A. Rossi, A. Gallamini, E. Chamorey, 2017 .

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

J. Raemaekers, G. Salles, D. de Jong, 2017, European journal of cancer.

Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes.

N. Magné, R. Largillier, E. Chamorey, 2004, Medical science monitor : international medical journal of experimental and clinical research.

Influence of sex and age on fluorouracil clearance.

F. Demard, J. Santini, G. Milano, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Focused ultrasound for the treatment of bone metastases: effectiveness and feasibility

A. Iannessi, A. Thyss, A. Bertrand, 2018, Journal of therapeutic ultrasound.

Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer

M. Namer, G. Milano, A. Thyss, 2005, Breast Cancer Research and Treatment.

Recurrent desmoid tumour on a gortex patch.

P. Bondiau, P. Marcy, F. Peyrade, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

X. Pivot, G. Milano, P. Canal, 2000, European journal of cancer.

Population study of dihydropyrimidine dehydrogenase in cancer patients.

F Demard, G Milano, O. Dassonville, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Subcutaneous rhabdomyosarcoma in children. Clinical, immunologic and ultrastructural aspects].

J. Valla, J. Lacour, A. Thyss, 1988, Annales de dermatologie et de venereologie.

ELYPSE 2: A prospective randomized trial comparing filgrastim (G-CSF) in primary and secondary prophylaxis in patients (pts) at high risk for febrile neutropenia (FN).

J. Blay, A. Le Cesne, P. Biron, 2006, Journal of Clinical Oncology.

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.

J. Thariat, L. Juillard, G. Deray, 2013 .

Acute pancreatitis following octreotide withdrawal.

D. Benchimol, A. Thyss, P. Freychet, 1991, The American journal of medicine.

Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS).

J. Michiels, A. Thyss, P. Hofman, 1993, Pathology, research and practice.

Toxoplasma cystitis associated with acquired immunodeficiency syndrome.

H. Quintens, A. Thyss, P. Hofman, 1993, Urology.

Myoma Hot Spot: Tumor-to-Tumor Metastasis of Thyroid Origin into Uterine Leiomyoma

P. Marcy, A. Iannessi, A. Lacout, 2019, European Thyroid Journal.

Granulocytic sarcoma with meningeal leukemia but no bone marrow involvement at presentation. A report of two cases with characteristic cerebrospinal fluid cytology.

J. Lagrange, M. Gaspard, A. Thyss, 1992, Acta cytologica.

Polyamines as biological markers in malignant lymphomas.

G. Milano, A. Thyss, C. Caldani, 1982, European journal of cancer & clinical oncology.

Metastatic Ablation for Sarcomas: Methodological and Ethical Dilemmas for Prospective Studies.

J. Thariat, A. Thyss, A. Falk, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Removal of methotrexate by hemodiafiltration

G. Milano, É. Cassuto, A. Thyss, 2004, Cancer Chemotherapy and Pharmacology.

Spontaneous hematoma of the kidney simulating a nephroblastoma. Report of two cases.

J. Zucker, A. Thyss, D. Dupont, 1990, American Journal Of Pediatric Hematology/Oncology.

Conventional Dose Intensive Immunochemo therapy Regimen in an Adult Patient with Very Late Relapse of Burkitt's Lymphoma

F. Peyrade, A. Thyss, A. Italiano, 2007, Journal of chemotherapy.

Treatment outcome in infant acute lymphoblastic leukemia

A. Uyttebroeck, S. Suciu, Y. Benoît, 2000 .

Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer.

A. Uyttebroeck, S. Suciu, Y. Benoît, 2000, Blood.

Non-renal urological lymphomas.

J. Drouillard, A. Thyss, J. Bruneton, 1987, RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print).

Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.

M. Candito, S. Bekri, A. Thyss, 1996, Medical and pediatric oncology.

Primitive Neuroectodermal Tumor of the Pelvis in an Elderly Patient

J. Thariat, P. Follana, J. Haudebourg, 2009, Oncology Research and Treatment.

Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.

R. Tubiana, C. Sebban, É. Lepage, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymphomatous superficial lymph nodes: US detection.

C. Balu-Maestro, A. Thyss, J. Bruneton, 1987, Radiology.

Brentuximab vedotin and bendamustine as first-line treatment of Hodgkin lymphoma in the elderly (HALO Trial).

A. Rossi, R. Schiappa, A. Gallamini, 2020 .

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

H. Gerhartz, M. Baccarani, F. Mandelli, 1992, Annals of Hematology.

Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib

G. Robert, P. Auberger, P. Hofman, 2014, Oncoscience.

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.

B. Coiffier, É. Oksenhendler, C. Gisselbrecht, 1993, The American journal of medicine.

A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia.

A. Thyss, P. Dellamonica, A. Deville, 1991, Acta dermato-venereologica.

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.

B. Pégourié, B. Grosbois, J. Mary, 2006, Blood.

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

J. Verweij, M. Glabbeke, M. Schlemmer, 2008, European journal of cancer.

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

J. Rossi, R. Gressin, E. Deconinck, 2010, British journal of haematology.

Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patients.

N. Magné, F. Demard, X. Pivot, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.

A. Italiano, J. Thariat, P. Maingon, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.

J. Radford, L. Trümper, L. Arcaini, 2016, The Lancet. Oncology.

High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma

D. Coso, H. Naman, F. Peyrade, 2015, Leukemia & lymphoma.

Amifostine Can Reduce Oral Mucositis after High-Dose Melphalan Conditioning in Patients with Multiple Myeloma: A Retrospective Study.

A. Italiano, F. Peyrade, E. Chamorey, 2004 .

Rechallenge with trabectedin in patients with locally advanced or metastatic soft tissue sarcoma following drug holiday: The experience of the French Sarcoma Group (FSG).

J. Blay, B. Bui, A. Cesne, 2012 .

[Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance].

F. Demard, G. Milano, R. Fleming, 1992, Bulletin du cancer.

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.

F. Bertucci, M. Toulmonde, A. Le Cesne, 2015, The Lancet. Oncology.